Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Maris

Showing results (81-90 of 458) with videos related to

Pageof 46
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 19, 2003
Detection of single-copy chromosome 17q gain in human neuroblastomas using real-time quantitative polymerase chain reactionMichael Morowitz, Suzanne Shusterman, Yael Mosse, et al.
Nature Genetics|March 4, 2000
Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1K E Nichols, J D Crispino, M Poncz, et al.
Pediatric Blood & Cancer|October 19, 2004
Tumor response and toxicity with multiple infusions of high dose 131I-MIBG for refractory neuroblastomaJames P Howard, John M Maris, Leslie S Kersun, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 7, 2008
Hepatic absorbed radiation dosimetry during I-131 metaiodobenzylguanidine (MIBG) therapy for refractory neuroblastomaKenneth F Koral, John P Huberty, Bill Frame, et al.
Endocrinology|December 7, 2000
The tetrabasic KKKK(147-150) motif determines intracrine regulatory effects of PthrP 1-173 on chondrocyte PPi metabolism and matrix synthesisR S Goomer, K A Johnson, D W Burton, et al.
Cancer Research|February 24, 2001
Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastomaP M Thompson, J M Maris, M D Hogarty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2005
Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group StudyMary Lou Schmidt, Ashutosh Lal, Robert C Seeger, et al.
Molecular Cancer Research : MCR|May 29, 2008
A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor geneKristina A Cole, Edward F Attiyeh, Yael P Mosse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2010
Phase II study of irinotecan and temozolomide in children with relapsed or refractory neuroblastoma: a Children's Oncology Group studyRochelle Bagatell, Wendy B London, Lars M Wagner, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
Human Krüppel-related 3 (HKR3): a candidate for the 1p36 neuroblastoma tumour suppressor gene?J M Maris, J Jensen, E P Sulman, et al.
Pageof 46

Showing results (81-90 of 458) with videos related to

Sort By:
Pageof 46
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 19, 2003
Detection of single-copy chromosome 17q gain in human neuroblastomas using real-time quantitative polymerase chain reactionMichael Morowitz, Suzanne Shusterman, Yael Mosse, et al.
Nature Genetics|March 4, 2000
Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1K E Nichols, J D Crispino, M Poncz, et al.
Pediatric Blood & Cancer|October 19, 2004
Tumor response and toxicity with multiple infusions of high dose 131I-MIBG for refractory neuroblastomaJames P Howard, John M Maris, Leslie S Kersun, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 7, 2008
Hepatic absorbed radiation dosimetry during I-131 metaiodobenzylguanidine (MIBG) therapy for refractory neuroblastomaKenneth F Koral, John P Huberty, Bill Frame, et al.
Endocrinology|December 7, 2000
The tetrabasic KKKK(147-150) motif determines intracrine regulatory effects of PthrP 1-173 on chondrocyte PPi metabolism and matrix synthesisR S Goomer, K A Johnson, D W Burton, et al.
Cancer Research|February 24, 2001
Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastomaP M Thompson, J M Maris, M D Hogarty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2005
Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group StudyMary Lou Schmidt, Ashutosh Lal, Robert C Seeger, et al.
Molecular Cancer Research : MCR|May 29, 2008
A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor geneKristina A Cole, Edward F Attiyeh, Yael P Mosse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2010
Phase II study of irinotecan and temozolomide in children with relapsed or refractory neuroblastoma: a Children's Oncology Group studyRochelle Bagatell, Wendy B London, Lars M Wagner, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
Human Krüppel-related 3 (HKR3): a candidate for the 1p36 neuroblastoma tumour suppressor gene?J M Maris, J Jensen, E P Sulman, et al.
Pageof 46